Company Filing History:
2 out of 60 
2 out of 17 
1 out of 5 Years Active: 2014-2019
Title: Holger Bindernagel: Innovator in Pharmaceutical Synthesis
Introduction
Holger Bindernagel is a notable inventor based in Gelnhausen, Germany. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 5 patents. His work focuses on innovative methods that enhance the efficiency and effectiveness of drug production.
Latest Patents
Among his latest patents, Bindernagel has developed methods for making onapristone intermediates. This patent outlines methods and systems for synthesizing onapristone intermediates, utilizing photoconversion techniques with a narrow band frequency light source. Additionally, he has created a purification method for epidaunorubicin, which involves the removal of the impurity epi-feudomycin, a by-product formed during the biotechnological production of epidaunorubicin.
Career Highlights
Throughout his career, Bindernagel has worked with prominent companies such as Heraeus Precious Metals GmbH & Co. KG and Medac Gesellschaft für Klinische Spezialpräparate mbH. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical technologies.
Collaborations
Bindernagel has collaborated with various professionals in his field, including Tero Kunnari and Sascha Weiser. These partnerships have fostered innovation and have been instrumental in the development of his patented methods.
Conclusion
Holger Bindernagel's contributions to pharmaceutical synthesis through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to influence the field and pave the way for future advancements in drug production.